secwatch.observer — SEC 8-K summary
======================================

Issuer:     ABBOTT LABORATORIES (ABT)
CIK:        0000001800
Form:       8-K
Filed at:   2026-03-09T23:59:59+00:00
Accession:  0001104659-26-025240
Event type: debt
Sentiment:  neutral
Materiality: 0.80
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Abbott completes $20B senior notes offering to fund Exact Sciences acquisition
------------------------------------------------------------------------------

- Issued $20B in eight tranches: Floating Rate Notes due 2029, fixed-rate notes from 3.700% to 5.600% with maturities 2029–2066.
- Net proceeds to fund Exact Sciences acquisition (announced Nov 2025), repay Exact Sciences debt, pay fees, and general purposes.
- If Exact Sciences acquisition not consummated by Feb 17, 2027, Abbott must redeem notes at 101% plus accrued interest.
- Underwriters include Morgan Stanley, Barclays, BofA Securities, J.P. Morgan.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1800/000110465926025240/0001104659-26-025240-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1800/000110465926025240/tm264905d8_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-025240

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer